Stereotaxis Inc (STXS) Stock Price, Quote & News

Company Profile

Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally. The company offers robotic magnetic navigation (RMN) systems, such as Genesis RMN, which enable physicians to complete complex interventional procedures by providing image-guided delivery of catheters through the blood vessels and chambers of the heart to treatment sites; and GenesisX RMN System, which is designed t...

Industry: Medical Instruments & Supplies

Sector: Healthcare

Phone: 314 678 6100

Website: www.stereotaxis.com

Address:

710 North Tucker Boulevard, Suite 110, Saint Louis, United States

Daquanladariusblackman3 Apr. 4 at 6:47 PM

$ABEO $DCTH $STXS 🚮🚮🚮

0 · Reply

Daquanladariusblackman3 Apr. 4 at 6:43 PM

$STXS going down like Monica Lewinsky in the early 2000s

0 · Reply

Daquanladariusblackman3 Apr. 4 at 6:27 PM

$MBOT yet again Eddy worry about your own investments. MBOT has a full market release of the liberty coming up this month with two hospitals already signed on for adoption. STXS on the other hand is hemorrhaging money, and keeps tanking lower, and lower, and lower. Much more likely that $STXS needs a reverse split, massive dilution, or a buyout to save their ass l. That ticker is dead money and your losses are large. @trigger_finger you starting to see why I’m hitting back on the $STXS board? This nonsense from this jackass and that hack @alexpitti has been going in for the better part of a year.

2 · Reply

trigger_finger Apr. 4 at 3:34 PM

$STXS And just like that, they added 1 new role and changed all the date posted to 4/1/26. Deceitful practice.....

0 · Reply

alexpitti Apr. 3 at 3:30 PM

Happy Easter 🐣 $STXS $DCTH $ABEO

1 · Reply

jb06000 Apr. 2 at 6:48 PM

$STXS AI and robotics will be a must. 30,000 deaths and 160,000 to 450,000 errors—are the centerpiece of a significant public health debate in France regarding "medical accidents" (accidents médicaux). These numbers primarily originate from a landmark study often cited by the AAVAC (Association d'Aide aux Victimes d'Accidents Corporels) and discussed in the "Black Book of Medicine" (Le Livre Noir de la médecine).

0 · Reply

Daquanladariusblackman3 Apr. 2 at 1:15 PM

$STXS 📉📉📉

0 · Reply

alexpitti Apr. 1 at 10:37 PM

$STXS david brought us from near bankruptcy to a full ecosystem of robotocs, software, and disposables. He is the man

0 · Reply

TonySoprano1987 Apr. 1 at 9:42 AM

$STXS i need $3 to move on here. Please give me it this year!

1 · Reply

cheating_stock_investor Mar. 31 at 11:18 PM

$STXS planning to buy some back again at these levels. Gonna start using margin as my core $SRRK position has built a base here especially with the news today.

0 · Reply

Stereotaxis: Medical Robotics Upside Offsets Cash Burn And Execution Risks

Mar 9, 2026, 8:17 PM EDT - 26 days ago

Stereotaxis, Inc. (STXS) Q4 2025 Earnings Call Transcript

Mar 9, 2026, 4:01 PM EDT - 26 days ago

Stereotaxis Reports 2025 Full Year Financial Results

Feb 12, 2026, 9:00 AM EST - 7 weeks ago

Stereotaxis to Report Fourth Quarter and Full Year 2025 Financial Results on March 9, 2026

Feb 9, 2026, 8:06 AM EST - 7 weeks ago

Klinikum Fürth Establishes Leading Robotic Heart Arrhythmia Program

Jan 6, 2026, 8:01 AM EST - 3 months ago

Stereotaxis Receives FDA Approval for MAGiC Ablation Catheter

Nov 24, 2025, 8:58 AM EST - 4 months ago

Stereotaxis to Participate in Piper Sandler 37th Annual Healthcare Conference

Nov 11, 2025, 7:51 PM EST - 5 months ago

Stereotaxis, Inc. (STXS) Q3 2025 Earnings Call Transcript

Nov 11, 2025, 4:01 PM EST - 5 months ago

Stereotaxis Reports 2025 Third Quarter Financial Results

Nov 10, 2025, 4:05 PM EST - 5 months ago

GenesisX Robotic Magnetic Navigation System Receives U.S. FDA Clearance

Oct 21, 2025, 9:00 AM EDT - 5 months ago

Stereotaxis to Report Third Quarter 2025 Financial Results on November 11, 2025

Oct 15, 2025, 7:32 AM EDT - 6 months ago

Stereotaxis Announces EU Launch and 510(k) Submission for Synchrony System to Modernize Interventional Cath Labs

Oct 13, 2025, 7:34 AM EDT - 6 months ago

Stereotaxis & CardioFocus Collaborate to Advance Robotic Pulsed Field Ablation for Cardiac Arrhythmias

Sep 22, 2025, 7:56 AM EDT - 6 months ago

Erasmus Medical Center Advances Cardiovascular Care with Genesis Robotic System

Sep 2, 2025, 8:08 AM EDT - 7 months ago

First US Commercial Robotic HD Mapping Procedures Successfully Completed with MAGiC Sweep Catheter

Sep 2, 2025, 7:51 AM EDT - 7 months ago

Stereotaxis to Present at Upcoming Investor Conferences

Aug 28, 2025, 7:47 AM EDT - 7 months ago

Stereotaxis Technology to be Featured at Heart Rhythm Society's HRX 2025

Aug 8, 2025, 1:24 PM EDT - 8 months ago

Stereotaxis, Inc. (STXS) Q2 2025 Earnings Call Transcript

Aug 7, 2025, 4:01 PM EDT - 8 months ago

Stereotaxis Reports 2025 Second Quarter Financial Results

Jul 28, 2025, 7:48 AM EDT - 8 months ago

Stereotaxis Receives U.S. FDA Clearance for MAGiC Sweep Catheter

Jul 23, 2025, 8:00 AM EDT - 9 months ago

Stereotaxis to Report Second Quarter 2025 Financial Results on August 7, 2025

Jul 17, 2025, 8:32 AM EDT - 9 months ago

Stereotaxis Announces $12.5 Million Registered Direct Offering of Common Stock

Jul 6, 2025, 2:13 AM EDT - 9 months ago

Stereotaxis: Recurring Revenue Inflection

Jul 1, 2025, 9:00 AM EDT - 9 months ago

First Clinical Results from MAGiC Catheter Study Published in the Journal of Interventional Cardiac Electrophysiology

May 12, 2025, 7:04 PM EDT - 11 months ago

Stereotaxis, Inc. (STXS) Q1 2025 Earnings Call Transcript

May 12, 2025, 4:01 PM EDT - 11 months ago

Stereotaxis Reports 2025 First Quarter Financial Results

Apr 22, 2025, 7:00 AM EDT - 1 year ago

Stereotaxis to Report First Quarter 2025 Financial Results on May 12, 2025

Apr 21, 2025, 8:00 AM EDT - 1 year ago

Stereotaxis to Feature First-Ever Live Demo of GenesisX Robotic System at HRS 2025

Mar 19, 2025, 8:01 AM EDT - 1 year ago

Stereotaxis Highlighted by NVIDIA at GTC Artificial Intelligence Conference and Accepted into NVIDIA Connect Program

Mar 10, 2025, 8:02 AM EDT - 1 year ago

Stereotaxis to Present at 37th Annual Roth Conference

Mar 7, 2025, 9:10 AM EST - 1 year ago

Stereotaxis To Get FDA Approval Of MAGiC This Fall, Ending Cash Burn

Mar 3, 2025, 10:34 AM EST - 1 year ago

Stereotaxis, Inc. (STXS) Q4 2024 Earnings Call Transcript

Mar 3, 2025, 7:32 AM EST - 1 year ago

Stereotaxis Submits EMAGIN Catheter for Regulatory Clearance as it Pioneers Robotics for Endovascular Surgery

Mar 3, 2025, 7:31 AM EST - 1 year ago

Stereotaxis Submits First Ever Robotically Navigated High-Density EP Mapping Catheter for Regulatory Clearance

Mar 3, 2025, 7:30 AM EST - 1 year ago

Stereotaxis Reports 2024 Full Year Financial Results

Feb 25, 2025, 8:03 AM EST - 1 year ago

Stereotaxis to Present at 45th Annual TD Cowen Healthcare Conference

Feb 14, 2025, 10:41 AM EST - 1 year ago

Stock Market Sleeps On Stereotaxis MAGiC CE Mark

Feb 3, 2025, 4:05 PM EST - 1 year ago

Stereotaxis to Report Fourth Quarter and Full Year 2024 Financial Results on March 3, 2025

Jan 30, 2025, 8:09 AM EST - 1 year ago

Stereotaxis Announces First GenesisX Robotic System Order

Jan 27, 2025, 8:00 AM EST - 1 year ago

Stereotaxis Receives CE Mark Approval for the MAGiC Ablation Catheter

Jan 14, 2025, 7:21 AM EST - 1 year ago

Oulu University Hospital Enhances Leadership in Arrhythmia Care with Advanced Genesis Robotic Technology

Dec 9, 2024, 7:25 AM EST - 1 year ago

Magbot Robotic Magnetic Navigation Ablation Catheter Approved by China's NMPA

Dec 2, 2024, 8:45 AM EST - 1 year ago

Stereotaxis' GenesisX Robotic System to be Showcased for the First Time at RSNA 2024 by Neusoft Medical Systems

Dec 2, 2024, 5:03 AM EST - 1 year ago

Stereotaxis To Drive Transformational Growth Via Full Ecosystem Launch In 2025

Nov 26, 2024, 8:28 AM EST - 1 year ago

Stereotaxis to Participate in Piper Sandler 36th Annual Healthcare Conference

Nov 25, 2024, 8:21 AM EST - 1 year ago

Stereotaxis Genesis Robotic System Achieves Regulatory Approval in China

Nov 20, 2024, 8:18 AM EST - 1 year ago

Hospital Da Luz is the First in Portugal to Adopt Genesis Robotic System

Nov 11, 2024, 7:03 PM EST - 1 year ago

Stereotaxis, Inc. (STXS) Q3 2024 Earnings Call Transcript

Nov 11, 2024, 4:02 PM EST - 1 year ago

Stereotaxis Reports 2024 Third Quarter Financial Results

Oct 21, 2024, 8:41 AM EDT - 1 year ago

Stereotaxis Technology to be Featured at Annual Meeting of the Society for Cardiac Robotic Navigation

Daquanladariusblackman3 Apr. 4 at 6:47 PM

$ABEO $DCTH $STXS 🚮🚮🚮

0 · Reply

Daquanladariusblackman3 Apr. 4 at 6:43 PM

$STXS going down like Monica Lewinsky in the early 2000s

0 · Reply

Daquanladariusblackman3 Apr. 4 at 6:27 PM

2 · Reply

trigger_finger Apr. 4 at 3:34 PM

$STXS And just like that, they added 1 new role and changed all the date posted to 4/1/26. Deceitful practice.....

0 · Reply

alexpitti Apr. 3 at 3:30 PM

Happy Easter 🐣 $STXS $DCTH $ABEO

1 · Reply

jb06000 Apr. 2 at 6:48 PM

0 · Reply

Daquanladariusblackman3 Apr. 2 at 1:15 PM

$STXS 📉📉📉

0 · Reply

alexpitti Apr. 1 at 10:37 PM

$STXS david brought us from near bankruptcy to a full ecosystem of robotocs, software, and disposables. He is the man

0 · Reply

TonySoprano1987 Apr. 1 at 9:42 AM

$STXS i need $3 to move on here. Please give me it this year!

1 · Reply

cheating_stock_investor Mar. 31 at 11:18 PM

$STXS planning to buy some back again at these levels. Gonna start using margin as my core $SRRK position has built a base here especially with the news today.

0 · Reply

jb06000 Mar. 31 at 6:47 PM

$STXS As a AI principal software developer this is great for us. This open great new opportunities.

5 · Reply

Daquanladariusblackman3 Mar. 31 at 6:10 PM

$STXS operating costs outweigh revenue. Absolute 🚮🚮🚮. Going bankrupt. Needs cash desperately. It’s either dilute or bankruptcy. There is no positive outcome here

1 · Reply

jb06000 Mar. 31 at 6:01 PM

$STXS it looks like infrastructure building. They’ve spent years building the "brain" (the robot); now they are hiring the "muscles" to build and sell the "razor blades" (the catheters). St. Louis, MO: This is their HQ. Hiring "Senior Full Stack Developers" and "Electrical Engineers" here suggests they are still iterating on the Synchrony Digital Surgery Suite and adding AI features to their platform. Minneapolis, MN: This is the hub for their 2024 acquisition, Access Point Technologies (APT). The "Extrusion Manager" and "Production Operator" roles here are critical because this is where the actual physical catheters (disposables) are manufactured. Regional Hubs (LA, PA, OH): These "Territory Assistant" roles are "boots on the ground" to support clinical adoption and ensure doctors are actually using the robots once installed.

0 · Reply

Daquanladariusblackman3 Mar. 31 at 3:10 PM

$STXS

1 · Reply

TheInvOb Mar. 31 at 12:11 PM

$STXS Been thinking a lot lately... I once thought STXS could be a Baby ISRG. but in today's world, I'm not sure that the modern economy has the patience for a company to slowly build like ISRG did. They've got customers... They've got a few venues and a couple orders, but production seems to be the block here. Scalability requires major funds and they're never going to raise that at 2 bucks or less. So my thinking now is starting to hedge toward buyout but I have no confidence it's any time soon.... Curious what others might be thinking longer term for the actual real logical business sustainability in an environment where it seems it's going to take a lot more cash to grow than they have. My opinion of course... What's yours?

0 · Reply

Daquanladariusblackman3 Mar. 31 at 12:09 PM

$STXS oooo down again

0 · Reply

trigger_finger Mar. 31 at 1:49 AM

$STXS The big robot trade will come. I don't know if it will be this year or next year but all ships will rise, and there will be acquisitions. So it's not horrible to have flyers... Safer plays, but just throwing that out there.

0 · Reply

trigger_finger Mar. 31 at 1:44 AM

$STXS Just as reference point to track. They are now up to 17 open positions. They keep pushing out the date opened field. This is up from 15 in September time frame. I might get AI to create a perfect resume to see if I get contacted. I'll share it if I end up doing that. Purely entertainment purposes.

1 · Reply

DomLuminous Mar. 30 at 11:47 PM

$STXS what a grind. Either this thing just moons one day or it’s over. At least with bitcoin it ripped and crashed… this is nothing

1 · Reply

alexpitti Mar. 30 at 9:25 PM

guys follow me. i'm back on twitter $DCTH $STXS $RCEL $ABEO $PROF https://x.com/alex__pitti

0 · Reply

Daquanladariusblackman3 Mar. 30 at 4:25 PM

$STXS dead money, no hope for recovering losses. Operating costs in the red compared to revenue. Only hope is a buyout. You’ll be waiting for years just to maybe break even if your average is anything above $2. Get out now and cut your losses. @alexpitti (seeking alpha has-been) and @Eddypgil aka (eddy the pig) seething and underwater rn and forever until the realize losses

3 · Reply

trigger_finger Mar. 30 at 1:22 PM

$STXS The approximate yearly revenue model for a Genesis X unit for 2027.

1 · Reply

Market Cap	181.86M
Revenue (ttm)	32.38M
Net Income (ttm)	-21.64M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-66.83%
Debt to Equity Ratio	0.00

Volume	173,300
Avg Vol	458,526
Day's Range	N/A - N/A
Shares Out	97.25M
Stochastic %K	58%
Beta	1.43
Analysts	Strong Sell
Price Target	$4.20